Related Experiment Video
Updated: Jun 9, 2026
07:43
Plasmid Stability Analysis with Open-Source Droplet Microfluidics
Published on: December 27, 2024
Identifying stabilizers of plasmid DNA for pharmaceutical use.
Yuhong Zeng1, Joshua D Ramsey, Robert King
1Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas 66047, USA.
Journal of Pharmaceutical Sciences
|August 27, 2010
Summary
Researchers screened 37 compounds to find stabilizers for plasmid DNA (BHT-DNA) biopharmaceuticals. Sodium citrate emerged as the most effective stabilizer, significantly improving storage stability for plasmid DNA formulations.
Area of Science:
- Biopharmaceutical development
- Molecular biology
- Formulation science
Background:
- Plasmid DNA (BHT-DNA) based therapeutics require stable formulations for efficacy.
- Identifying suitable excipients is crucial for improving the storage stability of plasmid DNA biopharmaceuticals.
Purpose of the Study:
- To screen generally regarded as safe (GRAS) compounds for their potential as stabilizers for plasmid DNA formulations.
- To identify specific excipients that enhance the stability of BHT-DNA, a plasmid DNA-based therapeutic vaccine.
Main Methods:
- Biophysical characterization of BHT-DNA from bulk and finished product.
- Agarose gel electrophoresis assay to monitor supercoiled plasmid DNA content in various formulations.
- Excipient compatibility studies involving incubation at 40 °C for 30 days.
Main Results:
- Eight out of 37 tested excipients demonstrated improved retention of supercoil content compared to the control.
- Sodium citrate was identified as the most effective stabilizer, with optimal performance at an ionic strength of approximately 0.4.
- Malic acid, ethanol, and Pluronic F-68 were also found to be promising stabilizers for BHT-DNA.
Conclusions:
- Several GRAS compounds, notably sodium citrate, can significantly enhance the storage stability of plasmid DNA formulations.
- Identification of destabilizing compounds (e.g., ferrous chloride, ascorbic acid) is also critical for formulation development.
- The findings are potentially applicable to a broader range of plasmid DNA-based pharmaceuticals due to macromolecular similarities.
Related Concept Videos
01:28Plasmids
Plasmids are extrachromosomal DNA molecules found in bacteria, archaea, and some eukaryotic microbes like yeast. These small, circular DNA structures typically contain fewer than 30 genes, although some may exist linearly. Plasmids vary in their number within a cell, known as copy number. Single-copy plasmids are present in one copy per cell and multi-copy plasmids are present in multiple copies, reaching over 100 copies per cell.Plasmids usually replicate independently of the chromosomal DNA...
01:03Single-Strand DNA Binding Proteins
For successful DNA replication, the unwinding of double-stranded DNA must be accompanied by stabilization and protection of the separated single strands of the DNA. This crucial task is performed by single-strand DNA-binding (SSB) proteins. They bind to the DNA in a sequence-independent manner, which means that the nitrogenous bases of the DNA need not be present in a specific order for binding of SSB proteins to it. The binding of SSB proteins straightens single-stranded DNA (ssDNA) and makes...